130 related articles for article (PubMed ID: 6144454)
1. Transfusion of circulating stem cells.
McCarthy DM; Goldman JM
Crit Rev Clin Lab Sci; 1984; 20(1):1-24. PubMed ID: 6144454
[TBL] [Abstract][Full Text] [Related]
2. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
3. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
Douay L; Lopez M; Gorin NC; Nauman A; Giarratana MC; Laporte JP; Stachowiak J; Salmon C; Duhamel G
Int J Cell Cloning; 1986 Jul; 4(4):250-62. PubMed ID: 2875118
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo assessment of the viability of cryopreserved postmortem murine bone marrow cells.
Liu PI; Poon KC; Hong CC; Crook L; Liu SS; Eguchi M
Ann Clin Lab Sci; 1980; 10(2):165-8. PubMed ID: 7387123
[TBL] [Abstract][Full Text] [Related]
5. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
Haas R; Ho AD; Bredthauer U; Cayeux S; Egerer G; Knauf W; Hunstein W
Exp Hematol; 1990 Feb; 18(2):94-8. PubMed ID: 1968009
[TBL] [Abstract][Full Text] [Related]
6. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
7. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
8. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival.
Körbling M; Fliedner TM; Holle R; Magrin S; Baumann M; Holdermann E; Eberhardt K
Bone Marrow Transplant; 1991 May; 7(5):343-9. PubMed ID: 1676924
[TBL] [Abstract][Full Text] [Related]
9. Collection, storage and transfusion of blood stem cells for the treatment of hemopoietic failure.
Fliedner TM; Calvo W; Körbling M; Nothdurft W; Pflieger H; Ross W
Blood Cells; 1979 Jun; 5(2):313-28. PubMed ID: 45349
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
11. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML
Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells.
Kessinger A; Armitage JO; Landmark JD; Weisenburger DD
Exp Hematol; 1986 Mar; 14(3):192-6. PubMed ID: 2868909
[TBL] [Abstract][Full Text] [Related]
13. Hemopoietic colony forming units in fresh and cryopreserved peripheral blood cells of canines and man.
Debelak-Fehir KM; Catchatourian R; Epstein RB
Exp Hematol; 1975 Apr; 3(2):109-16. PubMed ID: 1095378
[TBL] [Abstract][Full Text] [Related]
14. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
15. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
16. High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
Kessinger A; Vose JM; Bierman PJ; Armitage JO
Exp Hematol; 1991 Nov; 19(10):1013-6. PubMed ID: 1680733
[TBL] [Abstract][Full Text] [Related]
17. [Future perspectives of bone marrow and stem cell activation for autologous transplantation].
Gerhartz H
Beitr Infusionsther; 1991; 28():254-8. PubMed ID: 1725633
[TBL] [Abstract][Full Text] [Related]
18. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
19. [Autologous haematopoietic stem cell transplantation. Preliminary results of a regional multicentric study (author's transl)].
Herve P; Rozenbaum A; Plouvier E; Lamy B; Flesh M; Farradji A; Bergerat JP; Adjizian JC; Behar C; Vu Van H; Philip T
Nouv Presse Med; 1981 May; 10(24):2001-6. PubMed ID: 6114477
[TBL] [Abstract][Full Text] [Related]
20. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
Richel DJ; Baars JW; Wijngaarden MJ; van der Schoot CE; Vlasveld LT; Rodenhuis S
Ned Tijdschr Geneeskd; 1993 Jan; 137(5):245-50. PubMed ID: 7679478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
